Biotech · Private company
Blue Earth Therapeutics Ltd
Track this companyFree. Adds Blue Earth Therapeutics Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 18F-rhPSMA-7.3 injection (in phase 1 only)Phase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Lutetium (177Lu) rhPSMA-10.1 InjectionPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- lutetium (177Lu) rhPSMA 10.1 and Pluvicto®Phase 1 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate CancerEARLY_PHASE1 · TERMINATED · started Oct 31, 2024ClinicalTrials.gov NCT06516510 · fetched Nov 12, 2026
- NeoAdjuvant Theranostic Lutetium Study: The Nautilus TrialPHASE1_PHASE2 · RECRUITING · started Mar 29, 2024ClinicalTrials.gov NCT06066437 · fetched Nov 12, 2026
- Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionPHASE1_PHASE2 · RECRUITING · started Jul 20, 2022ClinicalTrials.gov NCT05413850 · fetched Nov 12, 2026